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sociodemographic and psychopathological correlates at the population level are unknown.
Method:Obsessive–compulsive symptomdimensions andmental disorderswere assessedwith the
Composite International Diagnostic Interview3.0 in a random subsample (n=2804) of individuals
participating in a cross-sectional survey of the adult general population of six European countries.
Results: The lifetime prevalence of any obsessive–compulsive symptom dimensionwas 13%. Harm/
Checking was the most prevalent dimension (8%) followed by Somatic obsessions (5%) and
Symmetry/Ordering (3%). Femalesweremore likely to have symptoms in Contamination/Cleaning
(OR=3, 95%CI=1.06–8.51) and Somatic obsessions (OR=1.88, 95%CI=1.05–3.37). All symptom
dimensions were associated with an increased risk of most mental (but not physical) disorders.
There were some differences in prevalence between countries.
Limitations: The interference associated with each symptom dimension could not be assessed. Few
direct data are available on the validity of the CIDI to assess obsessive–compulsive symptom
dimensions.
Conclusions: Obsessive–compulsive symptom dimensions are relatively frequent in the general
population. Their sociodemographic and psychopathological correlates may be slightly different in
clinical and community samples. They are associated with an increased risk of most mental
disorders.
© 2009 Elsevier B.V. All rights reserved.Keywords:
Obsessive–compulsive disorder
Anxiety disorders
Epidemiologyitute of Psychiatry, PO69 De Crespigny Park Rd., London SE5 8AF, United Kingdom. Tel.: +44 207 848 0543;
. Fullana).
di Alonso, Matthias Angermeyer, Herbert Matschinger, Ronny Bruffaerts, Traolach S. Brugha, Giovanni de
asquet; Josep Maria Haro, Steven J. Katz; Ronald C. Kessler, Viviane Kovess, Jean Pierre Lépine, Johan Ormel,
All rights reserved.
292 M.A. Fullana et al. / Journal of Affective Disorders 124 (2010) 291–2991. Introduction
Obsessive–compulsive disorder (OCD) is a disablingmental
disorder characterised by the presence of intrusive thoughts,
images or impulses that cause anxiety (obsessions) and/or the
presence of repetitive overt or covert actions that are carried
out to decrease anxiety (compulsions) (American Psychiatric
Association, 1994). For a person tomeet full diagnostic criteria,
the symptoms must be frequent and sufficiently interfering.
The lifetime prevalence of OCD in the general population
is estimated to be in the region of 1–2% (Fontenelle et al.,
2006; Ruscio et al., 2008). However, obsessive–compulsive
(OC) symptoms may be much more prevalent in the general
population (e.g. Grabe et al., 2000; Ruscio et al., 2008) than
full-blown OCD is. These sub-syndromal symptoms have
received little attention but several studies have shown that
they are associated with moderate degrees of interference
and increased psychiatric morbidity (Fullana et al., 2009;
Grabe et al., 2000, 2001; Ruscio et al., 2008). Perhaps more
importantly, there is longitudinal evidence that sub-syndro-
mal levels of OC symptoms in childhood increase the risk of
full-blown OCD in adulthood (Fullana et al., 2009). These
findings underscore the importance of adopting a dimen-
sional approach to OCD. It is possible that the early
identification and treatment of sub-syndromal cases may
lead to reduced risk for OCD.
The content of OC symptoms is heterogeneous and two
patients with OCD may have very different clinical presenta-
tions. Factor and cluster analytical studies of measures of OC
symptoms in clinical samples have identified some symptom
dimensions that summarise this complex clinical presentation.
Contamination/Cleaning, Harm/Checking, Symmetry/Ordering,
and Hoarding are the most replicated dimensions, although
others (Sexual/Religious obsessions and Somatic obsessions)
have been proposed (Bloch et al., 2008; Mataix-Cols et al.,
2005). The finding that these OC symptom dimensions are
similar across the lifespan (Mataix-Cols et al., 2008; Stewart
et al., 2008), temporally stable in longitudinal studies (Mataix-
Cols et al., 2002; Rufer et al., 2005) and probably universal
(Matsunaga et al., 2008) further supports their validity.
Preliminary evidence also suggests that these OC symptom
dimensions have distinct genetic (Alsobrook et al., 1999;
Samuels et al., 2008) and neural correlates (Mataix-Cols and
van den Heuvel, 2006; van den Heuvel et al., 2008) and are
associated with a differential treatment response (Mataix-Cols
et al., 2005).
Information on these symptom dimensions has originated
almost exclusively from clinical samples. A few studies have
reported the prevalence of individual OC symptoms in the
general population (Fullana et al., 2009; Nestadt et al., 1994;
Stein et al., 1997) but only one study examined the prevalence
of OC symptoms or dimensions in the absence of other mental
disorders (Fullana et al., 2009). The latter is important in order
to determine the impact of these symptoms on the individual's
life, independently from their co-occurring psychiatric
disorders.
Little is known also about the sociodemographic corre-
lates of these dimensions in the general population. In clinical
samples, for example, Contamination/Cleaning symptoms are
more prevalent in females and Symmetry/Ordering symp-
toms in males (Labad et al., 2008) but it is unknown whetherthis is also true in the general population. One epidemiolog-
ical study showed that Hoarding is associated with male sex,
older age and low income (Samuels et al., 2008), but no data
is available for the other dimensions.
Finally, in clinical samples the presence of certain symptom
dimensions is associated with an increased risk for specific
mental disorders. For example, patients with Harm/Checking
symptoms have increased risk for anxiety and mood disorders
(Hasler et al., 2005). In contrast, in the general population, the
association between particular symptom types and psychiatric
disorders appears to be less specific (Fullana et al., 2009) but
more data is required to replicate and extend these findings.
In this study we analyzed data from the European Study of
the Epidemiology of Mental Disorders (ESEMeD) project in
order to clarify someof the above issues regardingOC symptom
dimensions in the community. Our research questions were:
what is the life time prevalence of OC symptom dimensions in
the European population?; are these symptom dimensions
associated with particular sociodemographic variables?; and
are they associated with the presence of certain psychiatric
conditions?
2. Method
2.1. Sample
TheEuropeanStudyof the EpidemiologyofMentalDisorders
(ESEMeD) project is a cross-sectional household survey repre-
sentative of thenon-institutionalised adults (ages 18or older) of
Belgium, France, Germany, Italy, The Netherlands, and Spain. A
stratified,multistage, clustered area, probability samplewithout
replacement design was used. Data for the project were
provided by 21,425 respondents. Overall weighted response
rate was 61.2%, rates ranging from 45.9% in France to 78.6% in
Spain. A full description of the ESEMeD study methodology can
be found elsewhere (Alonso et al., 2004).
The survey was administered in two parts. Part I was
administered to all respondents and included diagnostic
evaluation of most common mood and anxiety disorders as
well as detailed questions about their use of health services,
health status and main demographic characteristics. Part II
was administered to individuals found to have specific mood
and anxiety symptoms in part I (‘high risk’ individuals) plus a
25% random subsample of all the other respondents (without
these symptoms). Part II included questions about additional
disorders, risk factors and other correlates. The total number
of respondents who completed part II was 8796. Part II
individuals were weighted by the inverse of their probability
of selection in order to adjust for differential sampling. This
procedure ensures that the weighted part II sample is
representative of the whole sample and provides unbiased
estimates (Alonzo et al., 2003). More details about sampling
and weighting procedures are discussed elsewhere (Heeringa
et al., 2008). The questions regarding OC symptom dimen-
sions were asked to a random 33% of part II individuals. In this
article we present data from these respondents (n=2804).
2.2. Assessment of obsessive–compulsive symptom dimensions
The initial questions of the OCD section of the CIDI 3.0 (see
below) were used to assess OC symptom dimensions.
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life lasting two weeks or longer when most days you expe-
rienced any of the following unpleasant thoughts, images, or
impulses, or repeated behaviors that you felt compelled to do”.
The answers to the specific questions listed in Table 1 assessed
the major symptom dimensions of OCD: Contamination/
Cleaning; Harm/Checking; Symmetry/Ordering; Sexual/
religious; Hoarding; Moral issues; and Somatic obsessions.
Each of the endorsed symptom dimensions were coded
1=present or 0=absent.
2.3. Assessment of mental and physical disorders
Mental health status was assessed with the Composite
International Diagnostic Interview (CIDI) 3.0, which was
developed and adapted by the Coordinating Committee of the
WHOWorld Mental Health (WMH) Survey Initiative (Kessler
and Ustun, 2004). The validity of the CIDI has been reported
previously (Haro et al., 2006). Lifetime diagnoses included in
this paper were DSM-IV major depressive episode, dysthy-
mia, alcohol-related disorders and anxiety disorders (specific
phobia, agoraphobia, social phobia, generalized anxiety
disorder, panic disorder, and post-traumatic stress disorder).
The following lifetime groups were also generated: “pure”
anxiety disorder and “pure” mood disorder (participants
fulfilling criteria for any anxiety or any mood disorder
respectively that did not fulfill criteria for other mental
disorders), and any mental disorder (participants fulfilling
criteria for any lifetime mental disorder). Unfortunately, we
were not able to ascertain how many individuals fulfilled the
criteria for OCD in this sample because a skip logic error was
detected which terminated the OCD assessment prematurely
for some respondents before OCD had been ruled out.
Anyway, in this study we were not interested in OCD
diagnosis but in OC symptom dimensions.
Also included in the CIDI was a list of chronic physical
health conditions, which was used to generate the category
“any chronic physical condition” (present/absent) in order to
establish the specificity of the association between OC
symptom dimensions and mental disorders, independently
from overall illness status.
2.4. Statistical analysis
The percentage of individuals endorsing each OC symptom
dimension across age, gender, income, geographical area,Table 1
Specific questions for the assessment of obsessive–compulsive symptom dimension
Lead in statement Have you ever had a period in your life lasting 2
unpleasant thoughts, images, or impulses, or rep
OC symptom dimension Question
Contamination/Cleaning A recurrent concern about dirt, germs, contaminat
Harm/Checking A recurrent impulse either to check things like loc
mistake was not made or impulses to do terrible t
Symmetry/Ordering A recurrent impulse either to line things up, to o
an exactly defined order
Sexual/Religious obsessions Recurrent sexual or religious thoughts, images, o
Hoarding A compulsion to save things or hoard things
Moral issues Recurrent unpleasant thoughts about right and w
Somatic obsessions A recurrent concern that you or someone close tanxiety disorders, mood disorders and chronic physical condi-
tions was calculated. Logistic regression models adjusted for
age, gender, income and country were generated for each OC
symptom dimension as a dependent variable. Independent
variables included were those that were significant in bivariate
analyses. ORs adjusting for age, gender, income, country and
specific mental disorders were obtained to assess the associa-
tion between each symptomdimension and the presence of the
most common axis I disorders. Standard errors were estimated
using the Taylor series linearization method (LaVange et al.,
1996) implemented in SUDAAN V9.0.1, a statistical package
used to analyse data obtained from complex design surveys (i.e.
multistage, stratified, unequally weighted or clustered) (Re-
search Triangle Institute, 2004) Significance tests were per-
formed with Wald χ2tests, using Taylor series design-based
coefficient variance–covariance matrices. Significance tests
were all evaluated at the 0.05 level with two-sided tests, except
for between-group comparisons, where the Bonferroni correc-
tion for multiple comparisons was used (∝=0.005).
Effect coding was used to test any possible country effects.
This form of contrasting allows to test the deviation of each
country from an “average European” effect, the so called
grand mean (Hosmer and Lemeshow, 1989). In order to
obtain identification the effect for an arbitrary reference
category is estimated as the negative sum of all the other
effects, so that all effects sum up to zero. This negative sum
and the respective standard error can easily be computed and
none of the six country effects must be omitted during the
presentation of the computed logistic regression models, as
dummy coding would stipulate (Aiken and West, 1991).
Data were weighted to account for known probabilities of
selection as well as to restore age and gender distribution of
the population within countries and the relative dimension of
the population across countries.
3. Results
3.1. Lifetime prevalence of obsessive–compulsive symptom
dimensions
Theoverall lifetime prevalence of anyobsessive–compulsive
symptom dimension was 13%. For the whole sample, Harm/
Checking (7.8%)was themost prevalentdimension, followedby
Somatic obsessions (4.6%) and Symmetry/Ordering (3.1%). The
prevalence of Hoarding was 2.6% and that of Contamination/
Cleaning was 1.8% (Table 2).s in the ESEMeD study.
weeks or longer when most days you experienced any of the following
eated behaviors that you felt compelled to do?
ion, or feeling compelled to repeatedly wash, clean, or decontaminate things
ks or stoves, or to go back over things in your mind to make sure that a
hings to people or recurrent concerns that you might do something terrible
rder or arrange things, to touch things, to count things, or to do things in
r impulses that you found unpleasant, intrusive, and disturbing
rong, or a compulsion to pray over and over to ask forgiveness
o you had a terrible illness that hadn't yet caused any symptoms
Table 2
Description of the study sample and prevalence of obsessive–compulsive symptom dimensions according to different groups.
Sample characteristics Prevalence of obsessive–compulsive symptom dimensions
Any
symptom
dimension
Contamination/
Cleaning
Harm/
Checking
Symmetry/
Ordering
Hoarding Sexual/
Religious
Moral
issues
Somatic
obsessions
(n=456)
(n=73) (n=271) (n=122)
(n=98)
(n=36) (n=64) (n=146)
n % (SE) % (SE) % (SE) % (SE) % (SE) % (SE) % (SE) % (SE) % (SE)
Whole sample 2804 – 13 (0.92) 1.8 (0.32) 7.8 (0.76) 3.1 (0.46) 2.6 (0.40) 0.7 (0.19) 1.4 (0.27) 4.6 (0.54)
Age categories
18–24 211 11.5 (1.08) 11.8 (2.77) 3 (1.40) 7.2 (2.30) 2.2 (1.23) 1.6 (1.29) 0.9 (0.78) 1.7 (0.94) 5 (1.70)
25–49 1316 44.8 (1.50) 13.7 (1.40) 1.6 (0.42) 8.8 (1.22) 3.7 (0.77) 2.9 (0.64) 0.9 (0.34) 1.8 (0.51) 4.6 (0.79)
50+ 1277 43.7 (1.50) 12.7 (1.32) 1.7 (0.48) 7 (0.99) 2.7 (0.63) 2.5 (0.55) 0.5 (0.19) 0.9 (0.24) 4.5 (0.80)
p-value – – 0.8 0.626 0.489 0.482 0.669 0.601 0.233 0.971
Gender
Male 1152 47.9 (1.48) 9.1 (1.05) 0.7 (0.29) 5.6 (0.82) 2 (0.55) 2.2 (0.55) 0.9 (0.35) 1.4 (0.45) 2.5 (0.63)
Female 1652 52.1 (1.48) 16.6 (1.41) 2.9 (0.56) 9.9 (1.20) 4 (0.73) 2.9 (0.58) 0.6 (0.18) 1.4 (0.30) 6.5 (0.86)
p-value – – b0.001 b0.001 0.003 0.022 0.344 0.437 0.917 b0.001
Income a
Low 509 19.5 (1.15) 19 (2.50) 2.5 (0.68) 12.2 (2.09) 5.7 (1.44) 5.7 (1.52) 0.6 (0.23) 2.8 (1.01) 8.2 (1.85)
Low average 881 31.4 (1.38) 11.1 (1.52) 1.8 (0.64) 7.6 (1.39) 1.9 (0.62) 1.8 (0.47) 0.8 (0.35) 0.4 (0.17) 3 (0.64)
High average 926 32.3 (1.41) 11.9 (1.54) 1.5 (0.59) 6 (1.17) 3.4 (0.91) 1.9 (0.54) 1.1 (0.47) 1.9 (0.50) 4 (0.89)
High 488 16.8 (1.11) 11.7 (1.93) 1.6 (0.66) 6.8 (1.47) 1.6 (0.53) 1.7 (0.76) 0.2 (0.13) 0.4 (0.20) 3.7 (1.07)
p-value – – 0.046 0.707 0.084 0.030 0.099 0.091 0.001 0.062
Geographical
Rural 759 31.2 (1.43) 15.6 (1.80) 2 (0.59) 9.1 (1.43) 3.1 (0.72) 3.2 (0.78) 1.4 (0.53) 1.4 (0.53) 6 (1.04)
Midsize 1275 40.4 (1.45) 11.5 (1.32) 2.1 (0.61) 6.7 (1.07) 2.7 (0.66) 2.5 (0.65) 0.5 (0.23) 1.5 (0.48) 3.8 (0.79)
Large 770 28.4 (1.39) 12.3 (1.74) 1.1 (0.34) 8 (1.51) 3.6 (1.06) 2 (0.63) 0.4 (0.15) 1.2 (0.34) 4.2 (0.99)
p-value – – 0.169 0.210 0.386 0.772 0.520 0.183 0.827 0.205
Any anxiety disorder
Yes 594 14.1 (0.93) 26.3 (2.85) 4.7 (1.12) 17.3 (2.52) 6.3 (1.47) 5.6 (1.31) 2.3 (0.67) 2.7 (0.67) 11.7 (2.01)
No 2210 85.9 (0.93) 10.8 (0.93) 1.3 (0.33) 6.3 (0.76) 2.55 (0.48) 2.1 (0.41) 0.5 (0.20) 1.2 (0.30) 3.4 (0.52)
p-value – – b0.001 0.003 b0.001 0.015 0.010 0.008 0.036 b0.001
Any mood disorder
Yes 979 13.5 (0.66) 26.8 (2.02) 6.1 (1.06) 16.7 (1.78) 7.2 (1.30) 4.4 (0.80) 2 (0.57) 3.9 (0.77) 10.7 (1.47)
No 1825 86.5 (0.66) 10.9 (1.01) 1.2 (0.33) 6.5 (0.83) 2.4 (0.49) 2.3 (0.44) 0.6 (0.20) 1 (0.29) 3.6 (0.57)
p-value – – b0.001 b0.001 b0.001 b0.001 0.020 0.020 b0.001 b0.001
Any pure anxiety disorder
Yes 228 8.3 (0.82) 23 (4.14) 2.7 (1.23) 16.2 (3.71) 4.7 (1.97) 3.9 (1.81) 0.6 (0.37) 1.7 (0.73) 10.8 (3.04)
No 2576 91.7 (0.82) 12.1 (0.90) 1.7 (0.34) 7 (0.74) 2.9 (0.47) 2.5 (0.40) 0.8 (0.21) 1.4 (0.29) 4 (0.50)
p-value – – 0.010 0.475 0.017 0.388 0.449 0.802 0.702 0.027
Any pure mood disorder
Yes 979 13.5 (0.66) 24 (2.56) 5.6 (1.35) 15.2 (2.30) 6.6 (1.64) 2.4 (0.69) 0.7 (0.33) 3.4 (0.89) 9 (1.93)
No 1825 86.5 (0.66) 12 (0.97) 1.5 (0.33) 7.2 (0.79) 2.8 (0.48) 2.6 (0.43) 0.8 (0.21) 1.2 (0.29) 4 (0.55)
p-value – – b0.001 0.003 0.001 0.029 0.831 0.873 0.021 0.017
Any mental disorder
Yes 1519 74.1 (1.16) 22.7 (1.86) 4.4 (0.76) 14.5 (1.59) 5.5 (0.96) 4.3 (0.87) 1.5 (0.38) 2.7 (0.49) 9.3 (1.28)
No 1285 25.9 (1.16) 9.6 (1.03) 0.9 (0.35) 5.5 (0.84) 2.2 (0.53) 2 (0.44) 0.5 (0.23) 0.9 (0.33) 3 (0.56)
p-value – – b0.001 b0.001 b0.001 0.002 0.019 0.022 0.002 b0.001
Any chronic physical condition
Yes 2039 70.5 (1.42) 14.5 (1.14) 1.9 (0.39) 9 (0.95) 2.9 (0.49) 2.9 (0.51) 0.6 (0.20) 1.3 (0.31) 5.1 (0.69)
No 765 29.5 (1.42) 9.4 (1.43) 1.6 (0.58) 5.1 (1.11) 3.5 (1.04) 1.8 (0.60) 1 (0.45) 1.5 (0.52) 3.2 (0.73)
p-value – – 0.004 0.663 0.007 0.617 0.177 0.481 0.794 0.050
Unadjusted results.
Significant differences between-groups at µ=0.005 (Bonferroni correction) are highlighted in bold.
a With respect to median income in each country.
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2
The wording of the questions related to OC symptoms in the NCS-R and
ESEMeD studies were identical except for hoarding. Participants in the NCS-R
were asked about “a compulsion to save things or being unable to throw things
away that you no longer need”, i.e., both hoarding obsessions and compulsions
were assessed. In the ESEMeD study only hoarding compulsions were assessed
(“a compulsion to save things or hoard things”).
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the lifetime prevalence of any obsessive–compulsive symp-
tomwas 9.6%. In this group, the prevalence of Contamination/
Cleaning, Harm/Checking, Symmetry/Ordering, Hoarding,
Sexual/religious, Moral issues and Somatic obsessions were
respectively: 0.9%, 5.5%, 2.2%, 2%, 0.5%, 0.9% and 3% (Table 2).
3.2. Association with sociodemographic variables (univariate
analyses)
As seen in Table 2, the prevalence of symptom dimensions
was similar across age groups but women had a significantly
higher lifetime prevalence of Contamination/Cleaning, Harm/
Checking, and Somatic obsessions. The prevalence of most
symptom dimensions tended to be higher among low income
participants, although this difference only reached statistical
significance for Moral issues. There were no significant
differences in prevalence according to geographical areas
(i.e. rural, midsize towns or large cities).
3.3. Association with psychiatric and physical conditions
(univariate analyses)
The prevalence of most lifetime obsessive–compulsive
symptom dimensions was more than double in participants
with lifetime mental disorders, particularly mood disorders
(Table 2). Interestingly, the presence of any chronic physical
condition also increased theprevalence of obsessive–compulsive
symptoms albeit to a smaller degree (14.5% vs. 9.4%; p=0.004).
3.4. Multivariate analyses
Table 3 shows the factors associated with each OC
symptom dimension in the European population. Females
were more likely to have lifetime symptoms in two dimen-
sions: Contamination/Cleaning (OR=3, 95%CI=1.06–8.51)
and Somatic obsessions (OR=1.88, 95%CI=1.05–3.37).
Individuals with low income had higher odds of presenting
any of the symptom dimensions except Contamination/
Cleaning, Harm/Checking and Sexual/Religious obsessions as
compared to those with high income. Moreover, there was a
significant association between high average income and the
Moral issues dimension (OR 4.54, 95%CI=1.58–13.1).
Pure mood disorders increased the probability of Harm/
Checking (OR 2.93, 95%CI=1.56–5.52) and Somatic obses-
sions (OR 3.46, 95%CI=1.63–7.32), whereas pure anxiety
disorders increased the probability of all symptom dimen-
sions except Hoarding and Sexual/Religious obsessions.
Comorbidity of anxiety and mood disorders increased the
probability of all symptom dimensions. There was no
significant association between any of the symptom dimen-
sions and chronic physical disorders.
Multivariate analyses also showed that respondents in
France (OR 1.98, 95%CI=1.35–2.91) and Italy (OR 1.35, 95%
CI=1.01–1.79) had an increased risk and The Netherlands (OR
0.45, 95%CI=0.29–0.68) a decreased risk of “any symptom
dimension”when compared to the average of the six European
countries as the reference category. Differences also emerged
regarding specific dimensions, and for example, respondents in
Francehadan increased riskofHarm/Checking andrespondents
in Italy an increased risk of Somatic obsessions (see Table 3).3.5. Association with specific mental disorders
The presence of all symptom dimensions was significantly
associated with increased risk of most axis I disorders except
alcohol disorder, and, surprisingly, generalized anxiety
disorder (Table 4). Harm/Checking was the dimension that
increased the risk of most disorders. Hoarding symptoms
were significantly associatedwith increased risk of dysthymia
(OR 2.14, 95%CI=1.04–4.40), post-traumatic stress disorder
(OR 2.44, 95%CI=1.01–5.92), and specific phobia (OR 2.97,
95%CI=1.27–6.94). There were no specific dimension-disor-
der relationships.
4. Discussion
This is one of the very few reports of the lifetime prevalence
and correlates of specific OC symptom dimensions in a large
epidemiological sample. Four conclusions can be drawn from
the data.
First, OC symptom dimensions are highly prevalent in the
community. We found an overall lifetime prevalence of 13% for
any of the symptom dimensions, which is at least five times
higher than that of people meeting strict diagnostic criteria for
OCD (Ruscio et al., 2008). This prevalence is somewhat lower
than that reported in some other epidemiological studies
(Fullana et al., 2009; Ruscio et al., 2008; Stein et al., 1997).
However the current and previous studies differ in a number of
important ways that make it difficult to directly compare their
findings. Indeed, different studies employed different instru-
ments, assessed different number and types of OC symptoms
and used different time frames (e.g. lifetime vs. 1-year
prevalence). In our studywe used a relatively stringent criterion
whereby, to endorse a symptom, the individual must have a
period of his or her life lasting 2 weeks or longerwhenmost days
they experienced any obsessions and/or compulsions. This may
have resulted in more conservative prevalence estimates.
However, methodological differences do not appear to fully
explain the differences between the results of the current study
and those of the NCS-R (Ruscio et al., 2008), which used very
similar methods and instruments but reported a much higher
prevalence of “any obsession or compulsion” (28%)2. It is
therefore possible that other variables, such as cultural differ-
ences, may contribute to different prevalence of OC symptom
dimensions in different parts of the world, just as they influence
the prevalence of most mental disorders (Demyttenaere et al.,
2004). In support for this idea, we also found some slight
differences between European countries, despite the use of
identical instruments andmethods. It is of course not possible to
fully rule out the effect of methodological confounds, such the
adaptation of the instruments to different languages. Careful, in-
depth trans-cultural studies of OC symptoms are still lacking.
Wewere also able to estimate the lifetime prevalence of OC
symptomdimensions in individuals notmeeting criteria for any
Table 3
Effect of sociodemographic variables, mental and physical disorders and country on obsessive–compulsive symptom dimensions (multivariate model).
Any symptom
dimension
Contamination/
Cleaning
Harm/Checking Symmetry/Ordering Hoarding Sexual/Religious Moral issues Somatic obsessions
(n=456) (n=73)
(n=271) (n=122) (n=95) (n=36) (n=64) (n=146)
Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI Odds
ratio
95% CI
Age (Ref: 50+)
18–24 0.93 (0.51,1.69) 1.81 (0.59,5.57) 0.96 (0.45,2.04) 0.61 (0.17,2.17) 0.64 (0.11,3.60) 1.45 (0.23,9.25) 1.74 (0.52,5.82) 1.05 (0.46,2.41)
25–49 1.17 (0.84,1.65) 0.85 (0.35,2.08) 1.32 (0.86,2.04) 1.33 (0.71,2.47) 1.45 (0.73,2.85) 1.41 (0.48,4.18) 1.93 (0.82,4.57) 1.12 (0.67,1.89)
Sex (Ref: male) 1.57 (1.12,2.20) 3 (1.06,8.51) 1.37 (0.89,2.12) 1.79 (0.85,3.77) 1.34 (0.65,2.76) 0.54 (0.22,1.33) 0.84 (0.37,1.90) 1.88 (1.05,3.37)
Income (Ref: high)
Low 1.65 (0.97,2.81) 1.77 (0.68,4.59) 1.92 (1.03,3.60) 3.87 (1.54,9.74) 2.97 (0.97,9.08) 2.47 (0.53,11.5) 5.82 (1.65,20.6) 2.05 (0.91,4.62)
Low average 0.93 (0.56,1.54) 1.62 (0.52,5.00) 1.19 (0.64,2.21) 1.19 (0.45,3.16) 0.99 (0.33,3.02) 3.62 (0.69,19.1) 1.03 (0.31,3.42) 0.72 (0.34,1.54)
High average 1.03 (0.63,1.69) 1.39 (0.47,4.14) 0.94 (0.49,1.77) 2.15 (0.85,5.46) 1 (0.33,3.00) 4.63 (0.99,21.5) 4.54 (1.58,13.1) 1.09 (0.52,2.25)
Anxiety/Mood (Ref: no)
Pure mood 2.49 (1.50,4.14) 2.58 (0.76,8.76) 2.93 (1.56,5.52) 2.11 (0.75,5.98) 1.93 (0.61,6.06) 1.57 (0.39,6.36) 1.78 (0.54,5.89) 3.46 (1.63,7.32)
Pure anxiety 2.34 (1.57,3.48) 5.27 (1.88,14.8) 2.28 (1.35,3.86) 2.43 (1.14,5.17) 0.92 (0.38,2.18) 1.54 (0.42,5.65) 4.06 (1.64,10.0) 2.91 (1.57,5.38)
Comorbidity anxiety/Mood 3.32 (2.13,5.16) 6.75 (2.25,20.3) 2.8 (1.58,4.94) 3.13 (1.34,7.33) 3.17 (1.45,6.93) 8.5 (2.74,26.4) 4.99 (1.87,13.3) 4.63 (2.50,8.58)
Any chronic
Physical condition (Ref: no) 1.4 (0.94,2.07) 0.75 (0.32,1.76) 1.55 (0.92,2.63) 0.67 (0.34,1.35) 1.38 (0.60,3.18) 0.54 (0.15,1.94) 0.87 (0.33,2.24) 1.38 (0.76,2.48)
Country*
Belgium 0.95 (0.65,1.39) 0.86 (0.42,1.79) 1 (0.61,1.64) 1.51 (0.87,2.63) 1.85 (1.00,3.44) 1.33 (0.47,3.73) 0.71 (0.30,1.72) 0.43 (0.17,1.11)
France 1.98 (1.35,2.91) 1.65 (0.62,4.37) 2.64 (1.68,4.16) 1.99 (0.94,4.22) 1.94 (1.01,3.74) 3.9 (1.45,10.5) 1.25 (0.47,3.32) 1.23 (0.67,2.28)
Germany 0.91 (0.65,1.27) 0.66 (0.33,1.34) 0.9 (0.58,1.39) 0.51 (0.23,1.11) 0.41 (0.16,1.05) 0.83 (0.25,2.72) 0.83 (0.28,2.44) 1.4 (0.82,2.41)
Italy 1.35 (1.01,1.79) 1.78 (0.99,3.20) 1.34 (0.93,1.92) 1.12 (0.69,1.80) 1.87 (1.08,3.24) 0.44 (0.15,1.29) 1.65 (0.86,3.18) 2.15 (1.40,3.31)
The Netherlands 0.45 (0.29,0.68) 0.52 (0.17,1.55) 0.36 (0.20,0.64) 0.39 (0.20,0.78) 0.21 (0.09,0.49) 0.38 (0.10,1.50) 0.73 (0.27,1.93) 0.45 (0.19,1.10)
Spain 0.97 (0.70,1.34) 1.15 (0.52,2.58) 0.87 (0.57,1.32) 1.5 (0.82,2.73) 1.71 (0.79,3.70) 1.39 (0.54,3.59) 1.12 (0.60,2.12) 1.37 (0.73,2.57)
Logistic regression models for each OC symptom dimension controlling for age, gender, income and country. * Effect coding was used to test deviation of each country from an “average European”.
Significant associations are highlighted in bold.
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297M.A. Fullana et al. / Journal of Affective Disorders 124 (2010) 291–299mental disorder, whichwas in the region of 10%. Thesefindings
confirm those of a previous population-based study that
reported a 1-year prevalence of OC symptoms ranging between
13 and 17% (Fullana et al., 2009) and suggest that a substantial
proportion of the general population experience moderately
interfering OC symptoms, independently from the presence of
other mental disorders. While it is likely that many of these
individuals will never go on to develop full-blown OCD or
require treatment, there is at least one longitudinal study that
found that the presence of OC symptoms in childhood (age 11)
was associated with a 5-fold increase risk of full-blown OCD
20 years later (Fullana et al., 2009).
Second, the frequency of specific symptom dimensions in
the community does not correspond exactly with that reported
in clinical samples. In our sample, Harm/Checkingwas themost
prevalent dimension followed by Somatic obsessions and
Symmetry/Ordering. Like in a previous population-based
study (Fullana et al., 2009), Contamination/Cleaning symptoms
were relatively infrequent (2%). By contrast, in clinical samples,
Contamination/Cleaning tends to be the most frequently
endorsed symptoms (Mataix-Cols et al., 2005). The apparent
differences in prevalence of these symptoms, in epidemiolog-
ical vs. clinical samples may simply reflect that Contamination/
Cleaning symptoms are more easily recognized and diagnosed
by clinicians than other types of symptoms and therefore
appear to be over-represented in clinical samples.
Third, our data on the sociodemographic correlates of OC
symptom dimensions may shed light on previous inconsisten-
cies between clinical andepidemiological samples. For example,
althoughmost studies in clinical samples show a predominance
of females, the results from epidemiological samples are less
conclusive (Fontenelle and Hasler, 2008). Our data suggest that
the effect of gender on OC dimensionsmay account for some of
these inconsistencies,with females beingmore likely to present
with Contamination/Cleaning symptoms (and may be also
more likely to seek treatment and “inflate” clinical samples) as
well as Somatic obsessions. An alternative possibility is that in
the general population the prevalence of full-blown OCD is
higher in women whereas the prevalence of sub-syndromal
OCD is similar in both genders (Grabe et al., 2000).
Fourth, all symptom dimensions were associated with an
increased risk of most mental disorders and this was indepen-
dent from the presence of any chronic physical illness.
Consistent with previous clinical studies (Hasler et al., 2005)
the presence of Harm/Checking symptoms was most strongly
associated with a wide range of mental disorders. The speci-
ficity of the relationship with particular psychiatric disorders
was, however, less clear than inprevious clinical studies (Hasler
et al., 2005). It is also unclear from the data whether the
presence of certainmental disorders increases the likelihood of
having certain OC symptoms or vice versa.
4.1. Limitations
Our study has several limitations. First, we have no data
on the validity of the CIDI to assess symptom dimensions,
although a clinical reappraisal study of theNCS-R revealed good
concordance between CIDI and SCID diagnoses of DSM-IV OCD
(Ruscio et al., 2008). Furthermore, we were not able to assess
some characteristics of obsessions/compulsions such as the
ego-dystonic nature of obsessions or the impression that
298 M.A. Fullana et al. / Journal of Affective Disorders 124 (2010) 291–299compulsions are excessive and absurd. Also, in our study we
assessed sevenOC dimensionswhilemost clinical studies focus
on four to six dimensions. Second, we were also not able to
assess separately the interference caused by each dimension
and this should be a focus of future research. Furthermore, as
occurredwithother studies (Ruscio et al., 2008), sample sizes in
our analyses were relatively small for epidemiological stan-
dardsbecauseOCDwasassessed only in a subsample of thepart
II sample. Finally, we were not able to ascertain how many
individuals fulfilled criteria for OCD in this sample because of
the previously mentioned skip logic error, although this does
not affect the estimates for the prevalence of OC dimensions.
4.2. Implications
The results of our study have implications at different levels.
From a research point of view, they add to a growing body of
evidence showing thatOCphenomenaaremuchmoreprevalent
than OCD in the community. An important goal for future
research will be to understand why the symptoms develop into
full-blown in OCD in some individuals but not in others. Only
longitudinal designs will eventually answer this question.
Our results on the high prevalence of OC symptom
dimensions, in conjunction with previous data on the interfer-
ence associated with OC symptoms in the community suggest
that clinicians need to be aware of the distress that frequently
accompanies sub-syndromal cases of OCD. Furthermore, it
encourages the use of prevention strategies that may decrease
this distress and/or have an impact on the development of the
illness.
Finally, our results suggest that at least some previous
inconsistencies in the literature on the epidemiology of OCD
can be accounted for the heterogeneity (i.e., predominance of
some OC dimensions) of the samples studied and strongly
encourage that these dimensions be carefully measured in
future surveys.
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